DK2011880T3 - Taurin transportergen - Google Patents

Taurin transportergen

Info

Publication number
DK2011880T3
DK2011880T3 DK07741485.2T DK07741485T DK2011880T3 DK 2011880 T3 DK2011880 T3 DK 2011880T3 DK 07741485 T DK07741485 T DK 07741485T DK 2011880 T3 DK2011880 T3 DK 2011880T3
Authority
DK
Denmark
Prior art keywords
taurin
transportation
taurin transportation
Prior art date
Application number
DK07741485.2T
Other languages
English (en)
Inventor
Hisahiro Tabuchi
Tomoya Sugiyama
Saeko Tanaka
Satoshi Tainaka
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK2011880T3 publication Critical patent/DK2011880T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • C12N2500/33Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07741485.2T 2006-04-13 2007-04-12 Taurin transportergen DK2011880T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006110467 2006-04-13
PCT/JP2007/058049 WO2007119774A1 (ja) 2006-04-13 2007-04-12 タウリントランスポーター遺伝子

Publications (1)

Publication Number Publication Date
DK2011880T3 true DK2011880T3 (da) 2012-11-26

Family

ID=38609534

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07741485.2T DK2011880T3 (da) 2006-04-13 2007-04-12 Taurin transportergen

Country Status (12)

Country Link
US (1) US9238687B2 (da)
EP (2) EP2011880B1 (da)
JP (2) JP4977691B2 (da)
KR (1) KR101342172B1 (da)
CN (1) CN101421411B (da)
AU (1) AU2007239679B2 (da)
CA (1) CA2649148C (da)
DK (1) DK2011880T3 (da)
ES (1) ES2397383T3 (da)
HK (1) HK1128308A1 (da)
TW (1) TWI388664B (da)
WO (1) WO2007119774A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2649148C (en) 2006-04-13 2016-08-23 Chugai Seiyaku Kabushiki Kaisha Taurine transporter gene
US20100233759A1 (en) 2007-03-15 2010-09-16 Chugai Seiyaku Kabushiki Kaisha Method for production of polypeptide
DK2154244T3 (da) 2007-04-26 2017-06-12 Chugai Pharmaceutical Co Ltd Celledyrkningsfremgangsmåde hvor et syreberiget medium anvendes
MX2010001319A (es) * 2007-08-07 2010-06-01 Chugai Pharmaceutical Co Ltd Metodo para producir proteinas heterogeneas.
BRPI0818039A2 (pt) * 2007-10-15 2014-10-14 Chugai Pharmaceutical Co Ltd Método para produzir uma célula capaz de produção de alto rendimento de heteroproteínas.
KR101636086B1 (ko) * 2007-10-24 2016-07-04 추가이 세이야쿠 가부시키가이샤 이종 단백질 제조를 위한 세포 및 그것을 사용한 제조 방법
JP5749930B2 (ja) 2008-10-28 2015-07-15 中外製薬株式会社 ペプチド含有動物細胞培養用培地
WO2010084947A1 (ja) * 2009-01-23 2010-07-29 中外製薬株式会社 異種ポリペプチドの製造方法
US8741601B2 (en) 2009-04-22 2014-06-03 Chugai Seiyaku Kabushiki Kaisha Method for producing a cell capable of high-yield production of heteroproteins
JP6182066B2 (ja) * 2011-04-01 2017-08-16 中外製薬株式会社 組換えポリペプチドの製造方法
SG11201502801RA (en) * 2012-10-10 2015-06-29 Chugai Pharmaceutical Co Ltd Method for establishing modified host cell

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019812D0 (en) 1990-09-11 1990-10-24 Scotgen Ltd Novel antibodies for treatment and prevention of infection in animals and man
AU691469B2 (en) 1992-03-04 1998-05-21 Synaptic Pharmaceutical Corporation DNA encoding taurine and gaba transporters and uses thereof
US6225115B1 (en) * 1992-03-04 2001-05-01 Synaptic Pharmaceutical Corporation DNA encoding taurine and GABA transporters and uses thereof
JP3630453B2 (ja) 1994-09-30 2005-03-16 中外製薬株式会社 Il−6レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
AU695117B2 (en) 1994-10-06 1998-08-06 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with IL-1beta
JPH09203734A (ja) 1996-01-26 1997-08-05 Sumitomo Electric Ind Ltd 抗血清、抗体、リガンド及びそれらの検出方法
JPH1075787A (ja) 1996-09-02 1998-03-24 Asahi Chem Ind Co Ltd 変異型アラニンアミノトランスフェラーゼおよびその製造法
JPH10191984A (ja) 1997-01-09 1998-07-28 Oriental Yeast Co Ltd 活性型ヒトaltの製造法
DE19855313A1 (de) 1998-12-01 2000-06-08 Degussa Verfahren zur fermentativen Herstellung von D-Pantothensäure durch Verstärkung des panD-Gens in Mikroorganismen
DE60034954D1 (de) 1999-09-14 2007-07-05 Xenoport Inc Substrate und screeningverfahren für transportproteine
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
US20040234977A1 (en) 2001-05-14 2004-11-25 Da-Wei Gong Novel alanine transaminase enzyme and methods of use
EP1414948B1 (en) * 2001-07-10 2009-09-16 Biogen Idec Inc. Inhibition of apoptosis process and improvement of cell performance
JP5290489B2 (ja) 2001-11-08 2013-09-18 アッヴィ・バイオセラピューティクス・インコーポレイテッド Igg抗体の安定な液体医薬製剤
MXPA04006894A (es) 2002-01-18 2004-10-15 Cargill Inc Alanina 2,3 - aminomutasa.
IL152905A0 (en) 2002-11-17 2003-06-24 Univ Ramot Dopaminergic markers induction in neuronal-like cells isolated from adult human bone marrow stromal cells: implications for novel gene therapy strategy for parkinsons disease
US20050265983A1 (en) 2002-11-17 2005-12-01 Eldad Melamed Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
US20030165495A1 (en) 2003-04-01 2003-09-04 Carulli John P. Nucleic acids and polypeptides
WO2005076015A1 (en) * 2004-01-30 2005-08-18 Xenoport, Inc. Taurine transporter tau1 expressed in blood brain barrier cells
KR100789645B1 (ko) * 2004-04-14 2007-12-27 주식회사유한양행 B형 간염바이러스의 s-표면항원을 인식하는 인간화 항체및 이의 제조방법
NZ579543A (en) 2004-07-09 2011-07-29 Chugai Pharmaceutical Co Ltd Anti-glypican 3 antibody
KR20070060950A (ko) 2004-10-07 2007-06-13 가부시키가이샤 상기 경피·경점막 흡수 제제
JP2006110467A (ja) 2004-10-14 2006-04-27 Furukawa Co Ltd 半導体製造装置用燐分離装置
JO3058B1 (ar) 2005-04-29 2017-03-15 Applied Molecular Evolution Inc الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
WO2007056507A1 (en) 2005-11-09 2007-05-18 Abbott Laboratories Human bnp immunospecific antibodies
EP1983819A4 (en) 2005-12-23 2009-09-02 Arcadia Biosciences Inc NITROGEN EFFICIENT MONOCOTYLE PLANTS
CA2649148C (en) 2006-04-13 2016-08-23 Chugai Seiyaku Kabushiki Kaisha Taurine transporter gene
US20100233759A1 (en) 2007-03-15 2010-09-16 Chugai Seiyaku Kabushiki Kaisha Method for production of polypeptide
MX2010001319A (es) 2007-08-07 2010-06-01 Chugai Pharmaceutical Co Ltd Metodo para producir proteinas heterogeneas.
BRPI0818039A2 (pt) 2007-10-15 2014-10-14 Chugai Pharmaceutical Co Ltd Método para produzir uma célula capaz de produção de alto rendimento de heteroproteínas.
KR101636086B1 (ko) 2007-10-24 2016-07-04 추가이 세이야쿠 가부시키가이샤 이종 단백질 제조를 위한 세포 및 그것을 사용한 제조 방법
US8741601B2 (en) 2009-04-22 2014-06-03 Chugai Seiyaku Kabushiki Kaisha Method for producing a cell capable of high-yield production of heteroproteins

Also Published As

Publication number Publication date
KR101342172B1 (ko) 2013-12-20
EP2011880A1 (en) 2009-01-07
TW200806790A (en) 2008-02-01
EP2228450A1 (en) 2010-09-15
CN101421411B (zh) 2015-06-03
WO2007119774A1 (ja) 2007-10-25
JPWO2007119774A1 (ja) 2009-08-27
JP5399529B2 (ja) 2014-01-29
CA2649148A1 (en) 2007-10-25
KR20090007276A (ko) 2009-01-16
CN101421411A (zh) 2009-04-29
AU2007239679B2 (en) 2012-10-11
JP4977691B2 (ja) 2012-07-18
US9238687B2 (en) 2016-01-19
US20090191591A1 (en) 2009-07-30
EP2011880A4 (en) 2009-11-11
ES2397383T3 (es) 2013-03-06
HK1128308A1 (en) 2009-10-23
JP2012143247A (ja) 2012-08-02
CA2649148C (en) 2016-08-23
TWI388664B (zh) 2013-03-11
EP2011880B1 (en) 2012-10-24
AU2007239679A1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
BRPI0720886A2 (pt) Recipiente
ATE501940T1 (de) Behälteranordnung
DE602006021277D1 (de) Behälter
DE602006021279D1 (de) Behälter
DK2011880T3 (da) Taurin transportergen
DOS2006000040S (es) Contenedor
DE112006003701A5 (de) Palette
DE502007006720D1 (de) Flurförderzeug
ITMI20060096U1 (it) Involucro da spedizione
DE502006006842D1 (de) Behälter
DK2102085T3 (da) Transportindretning
DE112005003512A5 (de) Transportbehälter
ES1059661Y (es) Contenedor
DK2086334T3 (da) Transportindretning
ES1064346Y (es) Recipiente
ES1063085Y (es) Contenedor
ES1060819Y (es) Envase
DOS2005000217S (es) Contenedor
FI7410U1 (fi) Kuljetussäiliö
FI7037U1 (fi) Kuljetuskontti
FIU20060491U0 (fi) Kuljetussäiliö
SE0600669L (sv) Lastsäkring
ES1064385Y (es) Contenedor
ES1061906Y (es) Envase
ES1062288Y (es) Contenedor